Hepeel

Medicinal product

(Invented) name

Hepeel

Active substance (s)

Lycopodium clavatum D3/Chelidonium majus D4/Cinchona pubescens D3/Myristica fragrans D4/Silybum marianum D2/Phosphorus D6/Veratrum album D6/Citrullus colocynthis D6

Strength

30 mg/30 mg/30 mg/30 mg/15 mg/15 mg/60 mg/90 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

ATC code (s)

Marketing authorisation holder

Biologische Heilmittel Heel GmbH, Vokietija

Date of authorisation

1996-10-30

Date of renewal

2012-10-12

Documents

3090_1 Hepeel_tab RPP 151231 taisy.docx

Stage

Perregistruotas

Controlled?

Controlled substance type

Legal basis

16.2

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Lycopodium clavatum D3	30 mg
Chelidonium majus D4	30 mg
Cinchona pubescens D3	30 mg
Myristica fragrans D4	30 mg
Silybum marianum D2	15 mg
Phosphorus D6	15 mg
Veratrum album D6	60 mg
Citrullus colocynthis D6	90 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2883	8407	1008407	tablečių talpyklė	N50		Nereceptinis	LT/1/96/3090/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2012-10-12	Perregistruotas
1996-10-30	Registruotas